PSME4
Basic information
Region (hg38): 2:53864069-53970993
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PSME4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 63 | 64 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 63 | 4 | 0 |
Variants in PSME4
This is a list of pathogenic ClinVar variants found in the PSME4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-53866223-T-C | not specified | Uncertain significance (Oct 03, 2022) | ||
2-53866872-T-G | not specified | Uncertain significance (May 06, 2024) | ||
2-53866876-C-A | not specified | Uncertain significance (Feb 28, 2023) | ||
2-53874403-T-C | not specified | Uncertain significance (Jan 26, 2022) | ||
2-53874412-A-C | not specified | Uncertain significance (Jul 13, 2022) | ||
2-53874436-A-G | not specified | Uncertain significance (Nov 13, 2023) | ||
2-53874482-T-C | not specified | Uncertain significance (Jan 16, 2024) | ||
2-53887291-T-C | not specified | Uncertain significance (Jul 05, 2023) | ||
2-53887295-C-A | not specified | Uncertain significance (Jan 16, 2024) | ||
2-53887443-T-C | not specified | Uncertain significance (Jun 17, 2022) | ||
2-53887894-G-A | not specified | Uncertain significance (Apr 23, 2024) | ||
2-53888773-G-T | not specified | Uncertain significance (May 30, 2024) | ||
2-53890119-A-G | EBV-positive nodal T- and NK-cell lymphoma | Likely benign (-) | ||
2-53890132-T-C | not specified | Uncertain significance (Apr 19, 2023) | ||
2-53890148-C-A | not specified | Uncertain significance (Mar 28, 2024) | ||
2-53890201-T-G | not specified | Uncertain significance (Apr 04, 2023) | ||
2-53892811-T-A | not specified | Uncertain significance (Dec 21, 2023) | ||
2-53893690-C-T | not specified | Uncertain significance (Sep 20, 2023) | ||
2-53893693-C-T | not specified | Uncertain significance (Mar 28, 2024) | ||
2-53895054-C-T | not specified | Uncertain significance (Feb 10, 2023) | ||
2-53895596-A-G | not specified | Uncertain significance (Aug 04, 2023) | ||
2-53895644-T-C | not specified | Uncertain significance (Aug 20, 2023) | ||
2-53895659-T-C | not specified | Uncertain significance (Jun 22, 2023) | ||
2-53896815-G-A | not specified | Uncertain significance (Dec 27, 2022) | ||
2-53896833-T-C | not specified | Uncertain significance (May 07, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PSME4 | protein_coding | protein_coding | ENST00000404125 | 46 | 106774 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 4.20e-10 | 125725 | 0 | 22 | 125747 | 0.0000875 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.27 | 757 | 954 | 0.793 | 0.0000474 | 12080 |
Missense in Polyphen | 102 | 201.04 | 0.50736 | 2577 | ||
Synonymous | -1.29 | 369 | 339 | 1.09 | 0.0000166 | 3464 |
Loss of Function | 8.89 | 13 | 117 | 0.111 | 0.00000670 | 1340 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000578 | 0.0000578 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000110 | 0.000109 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000133 | 0.000123 |
Middle Eastern | 0.000110 | 0.000109 |
South Asian | 0.0000994 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Associated component of the proteasome that specifically recognizes acetylated histones and promotes ATP- and ubiquitin- independent degradation of core histones during spermatogenesis and DNA damage response. Recognizes and binds acetylated histones via its bromodomain-like (BRDL) region and activates the proteasome by opening the gated channel for substrate entry. Binds to the core proteasome via its C-terminus, which occupies the same binding sites as the proteasomal ATPases, opening the closed structure of the proteasome via an active gating mechanism. Component of the spermatoproteasome, a form of the proteasome specifically found in testis: binds to acetylated histones and promotes degradation of histones, thereby participating actively to the exchange of histones during spermatogenesis. Also involved in DNA damage response in somatic cells, by promoting degradation of histones following DNA double-strand breaks. {ECO:0000269|PubMed:12093752, ECO:0000269|PubMed:18845680, ECO:0000269|PubMed:22550082, ECO:0000269|PubMed:23706739}.;
- Pathway
- Proteasome - Homo sapiens (human);Post-translational protein modification;Metabolism of proteins;UCH proteinases;Neddylation;Ub-specific processing proteases;Deubiquitination
(Consensus)
Recessive Scores
- pRec
- 0.219
Intolerance Scores
- loftool
- 0.450
- rvis_EVS
- -1.05
- rvis_percentile_EVS
- 7.6
Haploinsufficiency Scores
- pHI
- 0.735
- hipred
- Y
- hipred_score
- 0.756
- ghis
- 0.582
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.595
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | High | Medium | High |
Cancer | High | Medium | High |
Mouse Genome Informatics
- Gene name
- Psme4
- Phenotype
- cellular phenotype; reproductive system phenotype;
Gene ontology
- Biological process
- DNA repair;cellular response to DNA damage stimulus;multicellular organism development;proteasomal ubiquitin-independent protein catabolic process;positive regulation of peptidase activity;protein deubiquitination;spermatogenesis, exchange of chromosomal proteins;post-translational protein modification
- Cellular component
- nucleus;nucleoplasm;cytosol;nuclear speck;spermatoproteasome complex
- Molecular function
- protein binding;peptidase activator activity;lysine-acetylated histone binding;proteasome binding